2018 International Congress Archives - Page 120 of 177

Patient and Caregiver Experience With Pantothenate Kinase-Associated Neurodegeneration

H. Jinnah, W. Lenderking, A. Collins, M. Escolar, T. Klopstock, M. Kruer, A. Videnovic, A. Robichaux-Viehoever, L. Swett, D. Revicki, R. Bender, R. Marshall (Atlanta, GA, USA)
Patient and Provider Experiences and Attitudes toward Rytary

S. Horn, D. Coughlin, J. Chou, F. Wang, M. Stacy, R. Dolhun, C. Kopil, N. Amondikar, A. Deik, H. Sarva (Philadelphia, PA, USA)
Patient Experience of Parkinson’s Disease Psychosis Management

P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, A. Shim, D. Fredericks (Miami, FL, USA)
Patient Perceptions of Dopaminergic Therapy Withdrawal in Parkinson’s disease

N. Kukreti, P. Trujillo-Diaz, N. Van Wouwe, D. Claassen (Nashville, TN, USA)
Patient Perspective in Multiple System Atrophy

A. Mahajan, Z. Mari (Detroit, MI, USA)
Patient with secondary dystonia treated with internal globus pallidus deep brain stimulation (GPi-DBS), 2 years results: A case report

O. Morsi, AE. Baidez, J. Jimenez, J. Lopez, G. Valero, B. Cuartero, M. Felipe, R. Carrasco, J. Zamarro (Murcia, Spain)
Patient’s Choice of Device-Based Treatments in Parkinson’s Disease

M. Kuzu Kumcu, S. Tezcan Aydemir, Ç. Ulukan, B. Bakırarar, C. Akbostancı (Ankara, Turkey)
Patients experiencing peak-dose dyskinesia use re-distribution of involuntary movement amplitude throughout their body to minimize the functional impact of dyskinesia

K. Lebel, E. Goubault, S. Bogard, C. Duval (Montréal, QC, Canada)
Patients with Parkinson’s disease and psychosis have altered structural connectivity of the executive and visual networks

P. Pal, A. Lenka, M. Ingalhalikar, A. Shah, J. Saini, S. Arumugham, S. Hegde, L. George, R. Yadav (Bangalore, India)
Patterns of dopamine transporter imaging in subtypes of Multiple System Atrophy

F.T. Liu, L.L. Bu, Y.J. Yang, P. Wu, C.T. Zuo, J. Wang (Shanghai, China)